Overuse alert: Pharmacogenomic testing for selection of antidepressant provides minimal, if any, benefit (PRIME)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Overuse Alert: Pharmacogenomic Testing for Selection of Antidepressant Provides Minimal, if Any, Benefit (PRIME)." EE+ POEM Archive, John Wiley & Sons, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315688/all/Overuse_alert:_Pharmacogenomic_testing_for_selection_of_antidepressant_provides_minimal__if_any__benefit__PRIME_.
Overuse alert: Pharmacogenomic testing for selection of antidepressant provides minimal, if any, benefit (PRIME). In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2024. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315688/all/Overuse_alert:_Pharmacogenomic_testing_for_selection_of_antidepressant_provides_minimal__if_any__benefit__PRIME_. Accessed December 6, 2024.
Overuse alert: Pharmacogenomic testing for selection of antidepressant provides minimal, if any, benefit (PRIME). (2024). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315688/all/Overuse_alert:_Pharmacogenomic_testing_for_selection_of_antidepressant_provides_minimal__if_any__benefit__PRIME_
Overuse Alert: Pharmacogenomic Testing for Selection of Antidepressant Provides Minimal, if Any, Benefit (PRIME) [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2024. [cited 2024 December 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315688/all/Overuse_alert:_Pharmacogenomic_testing_for_selection_of_antidepressant_provides_minimal__if_any__benefit__PRIME_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Overuse alert: Pharmacogenomic testing for selection of antidepressant provides minimal, if any, benefit (PRIME)
ID - 1315688
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315688/all/Overuse_alert:_Pharmacogenomic_testing_for_selection_of_antidepressant_provides_minimal__if_any__benefit__PRIME_
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -